Zobrazeno 1 - 10
of 13
pro vyhledávání: '"M. R. Valerio"'
Autor:
B. Trevisan, F. F. Pepe, I. Vallini, E. Montagna, D. Amoroso, R. Berardi, A. Butera, K. Cagossi, L. Cavanna, M. Ciccarese, S. Cinieri, E. Cretella, E. De Conciliis, A. Febbraro, F. Ferraù, A. Ferzi, A. Baldelli, A. Fontana, A. R. Gambaro, O. Garrone, V. Gebbia, D. Generali, L. Gianni, F. Giovanardi, A. Grassadonia, V. Leonardi, S. Sarti, A. Musolino, M. Nicolini, C. Putzu, F. Riccardi, D. Santini, M. G. Sarobba, M. G. Schintu, G. Scognamiglio, P. Spadaro, C. Taverniti, D. Toniolo, P. Tralongo, A. Turletti, R. Valenza, M. R. Valerio, P. Vici, L. Clivio, V. Torri, M. E. Cazzaniga, The VICTOR Study Group
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Nowadays, treatment of metastatic breast cancer (MBC) has been enriched with novel therapeutical strategies. Metronomic chemotherapy (mCHT) is a continuous and frequent administration of chemotherapy at a lower dose and so whit less toxicity
Externí odkaz:
https://doaj.org/article/ead6e1b17648435a854ffe97bf17b72e
Autor:
Alberto Firenze, Livio Blasi, Francesco Verderame, Alba La Sala, I. Fazio, Sergio Rizzo, Hector Soto-parra, Gianluca Mortillaro, Roberto Marchese, Maurizio Chiarenza, Giuseppe Agneta, M. Spada, Dario Piazza, Enrico Potenza, Helga Lipari, M. R. Valerio, Concetta Sergi, Sergio Baldari, Amato C, Alfio Di Grazia, F. Ferraù, Alessandro Bertani, Elena Roz, Vittorio Gebbia, Gianfranco Mancuso, A. Guarini
Publikováno v:
Pulmonary Therapy
To date, the virtual multidisciplinary tumor boards (vMTBs) are increasingly used to achieve high-quality treatment recommendations across health-care regions, which expands and develops the local MTB team to a regional or national expert network. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::237a8a2a86a01abf8807a392fc04d70b
https://doi.org/10.1007/s41030-021-00163-8
https://doi.org/10.1007/s41030-021-00163-8
Autor:
A. Misino, Luigi Manzione, Francesco Giuliani, Evaristo Maiello, I. Nugnes, Francesco Carrozza, Sante Romito, M. R. Valerio, Giuseppe Colucci, A. Capobianco
Publikováno v:
European Journal of Cancer Supplements. 6:107-112
Introduction Despite the large number of drugs active in AGC, no combination can be considered as the gold standard treatment. Modest increase have been obtained in overall survival with the most widely employed regimens such as CF or ECF, often obta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c69e2455efe44380e83320d6f77cc6d
https://doi.org/10.1016/j.ejcsup.2008.06.017
https://doi.org/10.1016/j.ejcsup.2008.06.017
Autor:
E. Durini, A. Amodio, Giuseppe Colucci, Francesca Conti, Salvatore Pisconti, Franca Belli, Vittorio Gebbia, Diana Giannarelli, Massimo Lopez, G. Pezzella, Nicola Gebbia, Patrizia Vici, Francesco Giotta, M. Brandi, M. R. Valerio
Publikováno v:
Journal of Clinical Oncology. 20:2689-2694
PURPOSE: This phase II multicenter trial was aimed at investigating the activity of epirubicin-vinorelbine combination as first-line chemotherapy in metastatic breast cancer patients. PATIENTS AND METHODS: Ninety-seven patients with metastatic breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d80718f1d03d4b6eb890292dd06dc377
https://doi.org/10.1200/jco.2002.06.039
https://doi.org/10.1200/jco.2002.06.039
Autor:
AGNESE, Valentina, AUGELLO, Claudia, BRUNO, Loredana, CAMMARERI, Patrizia, CASCIO, Sandra, GREGORIO, Valter, SISTO, Pasqua Sandra, SCORSALE, V. CAL, G. GARGANO, A. GULLO, G. LA ROCCA, M. R. VALERIO, DI FEDE G, MARTORANA A, BAZAN V. RUSSO A.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::738919f8e3ccabe50a981edac59de392
http://hdl.handle.net/10447/33601
http://hdl.handle.net/10447/33601
Autor:
GREGORIO, Valter, AGNESE, Valentina, AUGELLO, Claudia, BRUNO, Loredana, CAMMARERI, Patrizia, CASCIO, Sandra, GULLO, Arianna, SISTO, Pasqua Sandra, PASSANTINO, Rita, MORELLO, Vincenza, TOMASINO, Rosa Maria, DANIELE, Elio, BAZAN, Viviana, G. LA ROCCA, S. CORSALE, V. CAL, G. GARGANO, M. R. VALERIO, G. AGNELLO, A. MARTORANA, RUSSO, Antonio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::aa87926daa3542f31476680eb002a1ce
http://hdl.handle.net/10447/13307
http://hdl.handle.net/10447/13307
Autor:
BRUNO, Loredana, AUGELLO, Claudia, SISTO, Pasqua Sandra, S. CORSALE, G. GARGANO, V. CAL, G. LA ROCCA, AGNESE, Valentina, CAMMARERI, Patrizia, CASCIO, Sandra, GREGORIO, Valter, AGNELLO, Giuseppe, M. R. VALERIO, G. CICERO, G. DI FEDE, A. MARTORANA, BAZAN, Viviana, RUSSO, Antonio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::f7351f05f07184c9151e0e3db7ffca43
http://hdl.handle.net/10447/13893
http://hdl.handle.net/10447/13893
Autor:
Raffaela Anastasio, Giuseppe Badalamenti, C. Arcara, Ignazio Abbene, Alessandra Casuccio, M. R. Valerio, Sergio Siragusa, Fabio Fulfaro, Nicolo' Gebbia, Alessandra Malato
8531 Background: In patients with a first episode of idiopathic or provoked Deep Vein Thrombosis (DVT), the presence of Residual Vein Thrombosis (RVT), detected by UltraSonography (US) at the 3rd month from the index DVT, is an independent risk facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a366a0303dad93983a9075e918a63bb
http://hdl.handle.net/10447/7617
http://hdl.handle.net/10447/7617
Autor:
A. Calascibetta, R. Sanguedolce, Daniela Cabibi, Aragona F, J. Dispenza, Fabio Fulfaro, Antonino Martorana, M. R. Valerio, M. Brandi
10546 Background: Adjuvant chemotherapy is used in the treatment of breast carcinoma independently of axillar node involvement. Different drug combinations such as CMF, FAC, FEC are still used; recently new drugs such as TXT (NEJM 332:1004,1997) show
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3acad482e793968359ab741627013513
http://hdl.handle.net/10447/20882
http://hdl.handle.net/10447/20882
Autor:
F. Fulfaro, M. R. Valerio, G. Badalamenti, C. Arcara, G. Cicero, C. Intrivici, A. Crosta, C. Sciortino, A. Russo, N. Gebbia
Background: Paclitaxel-Doxorubicin combination chemotherapy is highly active in metastatic breast cancer patients (pts) but may be cardiotoxic in a small percentage of cases. PLD is a new formulation of Doxorubicin with significant reduced cardiac to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5e82bef92debc13ab2ca5aabc344b26
http://hdl.handle.net/10447/4179
http://hdl.handle.net/10447/4179